- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
VIVUS Inc+ Add to Watchlist
VVUS:US3.7500 USD 0.1100 2.85%
As of 20:10:00 ET on 10/01/2014.
Company Profile for VIVUS Inc (VVUS)
VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
Key Executives for VIVUS Inc (VVUS)
|Seth H Z FischerCEO/Chief Commercial Officer||Guy P MarshVP:US Ops/General Manager|
|Wesley W DayVP:Clinical Development|